COVID-19: Dr Hemant Thakkar Busts Myth About Hydroxychloroquine Being Anti-malarial

General News

Dr. Hemant Thakkar busted the myth around the use of hydroxychloroquine, which is said to be an anti-malarial drug for the prevention of COVID-19

Written By Jitesh Vachhatani | Mumbai | Updated On:

Dr. Hemant Thakkar, a notable practicing physician in Mumbai, busted the myth around the use of hydroxychloroquine, which is said to be an anti-malarial drug for the prevention of COVID-19 for a high-risk population. On the debate with Republic Media Network's editor-in-chief Arnab Goswami on Monday, Dr. Thakkar clarified that hydroxychloroquine is not an anti-malarial drug. "Hydroxy Chloroquine is not used in routine clinical practice for malaria," stated Dr. Thakkar on the debate. 

'Hydroxychloroquine has fewer side-effects'

Highlighting the recommendation of hydroxychloroquine by the Indian Council of Medical Research for the prevention of COVID-19 for high-risk populations, Dr. Thakkar said that hydroxychloroquine is a derivative of chloroquine, adding that in 2014, India was the only country to approve the use of hydroxychloroquine as an anti-diabetic drug. Dr. Thakkar also stated that hydroxychloroquine has lesser side-effects than chloroquine but it still has certain cardiac side-effects and hence, it cannot be just popped like candy. 

READ | BREAKTHROUGH: National Task Force Recommends Drug To Prevent COVID-19 For High-risk Cases

READ | US President Donald Trump Approves Use Of Anti-malarial Drug For Use Against COVID-19
 

First Published:
By 2030, 40% Indians will not have access to drinking water
SAVE WATER NOW
PEOPLE HAVE PLEDGED SO FAR
DO NOT MISS